November 07, 2018 | Staff
Professor Abdul Basit is the Formulation Director at FabRx and he holds the position of Professor of Pharmaceutics at the UCL School of Pharmacy, University College London. Abdul’s research sits at the interface between pharmaceutical science and gastroenterology, forging links between basic science and clinical outcomes. He is an international authority on oral drug delivery and absorption, and has published over 300 papers, book chapters, abstracts, and patents. He leads a large and multi-disciplinary research group, and the goal of his work is to further the understanding of gastrointestinal physiology by fundamental research. So far, this knowledge has been translated into the design of new technologies and improved disease treatments, many of which are currently in late stage clinical trials, his commercial view led to the creation of a drug delivery company, Intract Pharma. Abdul was the recipient of several awards including the Young Investigator Award in Pharmaceutics and Pharmaceutical Technology from the American Association of Pharmaceutical Scientists (AAPS), and is the only non-North American scientist to receive this award. He is a frequent speaker at international conferences, serves as a consultant to numerous pharmaceutical companies and is on the advisory boards of healthcare organizations, charitable bodies and scientific journals.
Copyright © 2018 FabRx Ltd
Website Design by Creative Brand Design